Research

Calvary is partnering with the University of Sydney to trial and evaluate a new program to help aged care residents with mild to moderate dementia remain healthy and independent. Known as the I-CHARP project (Interdisciplinary Care Home-based Reablement Program), this implementation research study is being funded by the National Health

By Kerryn Vine-Camp, Calvary National Director People & Corporate Services Thomas A Edison once said: “There’s a way to do it better – find it”. As a leading healthcare provider, Calvary recognises that to ensure ongoing research activities we must have an organisational strategy that attracts, retains and supports innovation

Approximately 450,000 Australians live with dementia – almost every one of us knows someone diagnosed with or has cared for someone with this neurodegenerative condition. Dementia is the second highest cause of death among Australians, and without a medical breakthrough, this number is expected to increase to nearly 900,000 Australians

Information for patients, aged care residents and visitors.

This week, 24-30 October, we celebrate Pastoral Care Week, also known as Spiritual Care Week. Pastoral Care is internationally celebrated for its inclusivity, regardless of whether the participants and recipients are religious or non-religious.

On Thursday 12th September, the National Palliative Care Awards were presented at the inaugural Oceanic Palliative Care Conference Gala Dinner in Perth. These prestigious national awards are presented every two years by Palliative Care Australia (PCA). Nominations are received from palliative care services across the country. Five individual and two

On 19 June the ‘Voluntary Assisted Dying Act 2017 (‘VAD’) comes into effect in Victoria. Since the Act’s passing in 2017, Catholic Health and Aged Care services in Victoria have been working together to ensure that we have a clear and consistent response to the Act. Our services are committed

A new report commissioned by Catholic Health Australia (CHA) calls for the provision of more home-based palliative care services to relieve pressure on hospitals and save valuable health system dollars. CHA, the peak body for Catholic health and aged care service providers in Australia, launched the report today at Calvary

Implementing and testing new methods of supporting people with dementia.

Clare Holland House Hospice was awarded ACT’s top award at the 2017 Quality in Healthcare ACT Awards presented  Monday evening 26th February. The awards honour initiatives that are improving the delivery of safe, quality health services to the ACT community. Minister for Health and Wellbeing Meegan Fitzharris and Minister for

An underlying mechanism linking obesity with the development of endometrial/uterine cancer has for the first time been demonstrated. Current statistics show that 57% of women who develop uterine cancer are obese, yet it hasn’t been clear how or why fat cells drive this particular cancer more than other tumour types.

A new palliative and end of life care research institute launched on 30th November by Little Company of Mary Health Care will profile the important research being undertaken in the field of Palliative and End of Life Care at four leading specialist palliative care services across Calvary.. “It would be reasonable

With a sense of unease and discomfort, Calvary noted several media articles over the weekend of 19 and 20 August 2017 which claim that the “Catholic church” is threatening to fire teachers, nurses and other employees who marry their same-sex partner if gay marriage is legalised. We reassure staff and

Professor John Forbes has received New South Wales highest cancer award for his contribution to the fight against the deadly disease.

Calvary Mater Newcastle cancer researchers take a lead role in exploring the use of advanced radiotherapy to treat prostate cancer. Calvary Mater Newcastle researchers, in collaboration with Liverpool Hospital in Sydney, have developed a treatment option for men with prostate cancer using stereotactic radiotherapy, which gives very high doses of